BIOMAT Database Logo BIOMAT Database Logo

High-dose intravenous gammaglobulin. 1985

H I Atrah, and R J Crawford, and G S Gabra, and R Mitchell

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D010973 Platelet Adhesiveness The process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other "foreign" surfaces. Adhesiveness, Platelet,Adhesivenesses, Platelet,Platelet Adhesivenesses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H I Atrah, and R J Crawford, and G S Gabra, and R Mitchell
High dose intravenous methylprednisolone or high dose intravenous gammaglobulin for autoimmune thrombocytopenia.
January 1988, British medical journal (Clinical research ed.),
H I Atrah, and R J Crawford, and G S Gabra, and R Mitchell
High-dose intravenous gammaglobulin therapy for uveitis.
January 1989, Metabolic, pediatric, and systemic ophthalmology (New York, N.Y. : 1985),
H I Atrah, and R J Crawford, and G S Gabra, and R Mitchell
High-dose intravenous gammaglobulin for myasthenia gravis.
April 1984, Lancet (London, England),
H I Atrah, and R J Crawford, and G S Gabra, and R Mitchell
High-dose intravenous gammaglobulin for Kawasaki disease.
November 1984, Lancet (London, England),
H I Atrah, and R J Crawford, and G S Gabra, and R Mitchell
High-dose intravenous gammaglobulin for myasthenia gravis.
February 1984, Lancet (London, England),
H I Atrah, and R J Crawford, and G S Gabra, and R Mitchell
High-dose intravenous gammaglobulin for Kawasaki disease.
December 1983, Lancet (London, England),
H I Atrah, and R J Crawford, and G S Gabra, and R Mitchell
High-dose intravenous gammaglobulin: a cautionary note.
February 1985, Lancet (London, England),
H I Atrah, and R J Crawford, and G S Gabra, and R Mitchell
Hepatitis associated with high dose intravenous gammaglobulin.
September 1993, Annals of allergy,
H I Atrah, and R J Crawford, and G S Gabra, and R Mitchell
High-dose intravenous gammaglobulin for membranous nephropathy.
December 1986, Clinical nephrology,
H I Atrah, and R J Crawford, and G S Gabra, and R Mitchell
High-dose intravenous gammaglobulin for myasthenia gravis.
October 1984, Lancet (London, England),
Copied contents to your clipboard!